Alzheimer's disease could be treated by the use of a molecular inhibitor molecule. The molecule may be able to halt the development of the disease. This disorder is the result of amyloid fibrils, a form of protein, improperly becoming attached to other proteins, creating clusters of the structures, eventually leading to the loss of cognitive function.
Brichos, a molecule now shown to arrest progression of the disease, develops naturally in the human body, researchers report. This molecule acts as a molecular chaperone, attaching to dysfunctional proteins, preventing them from forming the dangerous clusters.